Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
March 31, 2013
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Conditions
HIV
Interventions
DRUG
Eviplera®
Trial Locations (1)
SW10 9NH
St Stephen's AIDS Trust, London
All Listed Sponsors
lead
St Stephens Aids Trust
OTHER
NCT01796431 - Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers | Biotech Hunter | Biotech Hunter